Quantcast

Latest ACE inhibitors Stories

2012-01-12 21:02:24

Researchers at St. Michael's Hospital have published the first detailed figures showing the risk of using the prescription drug Rasilez in combination with certain other blood pressure-lowering medications. The pharmaceutical company Novartis terminated a large, international clinical trial of the drug last month after finding an increased incidence after 18-24 months of non-fatal strokes, renal complications, high levels of potassium in the blood and low blood pressure. As a result,...

2011-12-09 14:18:24

Different patients may respond differently to each drug Two seemingly similar blood pressure—lowering drugs have different effects on the heart health of dialysis patients, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results indicate that certain dialysis patients may benefit more from one drug while some should opt for the other. About 20% of kidney disease patients die within one year after they start dialysis...

2011-12-07 14:36:01

One study presented at the meeting, which is being held in Budapest, Hungary, 7 to 10 December, reports on an initiative using echocardiography to document early warning signs of adverse effects from trastuzumab (Herceptin ®)´, while the other uses echocardiography to evaluate the protective role of ACE inhibitors and statins on the hearts of cancer patients². "These studies open the way for the early identification of myocardial damage at the subclinical level, thereby...

2011-07-06 10:37:00

BALTIMORE, July 6, 2011 /PRNewswire/ -- Lupin Pharmaceuticals, Inc. (LPI) announced today that the U.S. Food and Drug Administration (US FDA) has granted final approval for its Amlodipine / Benazepril 5mg/40mg, and 10mg/40mg capsules. Commercial shipments of the product have already commenced. This approval completes the product line as the Company was granted final approval for Amlodipine / Benazepril 2.5mg/10mg, 5mg/10mg, 5mg/20mg and 10mg/20mg capsules in February 2010. Lupin's...

2011-04-29 13:37:39

The angiotensin-converting enzyme (ACE) inhibitor drug, ramipril, is particularly effective in lowering the risk of end-stage renal disease (ESRD) in obese patients, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). "Obese patients with kidney disease progress more quickly towards renal failure compared to non-obese patients, and ramipril virtually abolishes this excess risk," comments Carmine Zoccali, MD (CNR-IBIM and Ospedali...

2011-04-29 06:11:07

(Ivanhoe Newswire) --A drug used to treat high blood pressure may reduce the risk of kidney failure in obese patients. Research studies have found that an obese person is nearly seven-times more likely to develop kidney failure than a normal-weight person. An angiotensin-converting enzyme (ACE) inhibitor drug, known as ramipril, has proven to be effective in lowering the risk of end-stage renal disease (ESRD) in these patients. For the study, researchers analyzed data from another trial that...

2011-03-21 23:38:47

Elderly patients prescribed combination angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARB) had a higher risk of kidney failure and death, according to a study published in CMAJ (Canadian Medical Association Journal) . This study, by researchers from the University of Alberta and the University of Calgary, sought to determine the safety of combination therapy of ACE inhibitors and ARB in the clinical setting as some randomized trials indicate an increased...

2011-01-03 12:20:00

WOODCLIFF LAKE, N.J., Jan. 3, 2011 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it began shipping all strengths of amlodipine besylate and benazepril hydrochloride capsules, the generic version of Novartis' Lotrel®. Par has been awarded 180 days of marketing exclusivity for the 5/320mg and 10/320mg strengths, commencing at launch, for being the first to file an ANDA containing a paragraph IV certification for the product. According...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'karpos', fruit.
Related